本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Design Therapeutics, Inc.

3.40
-0.1200-3.41%
盘后3.400.00000.00%16:02 EDT
成交量:11.44万
成交额:39.01万
市值:1.93亿
市盈率:-3.88
高:3.66
开:3.41
低:3.30
收:3.52
数据加载中...
2025/03/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/13

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]